Harpoon Therapeutics announced Monday afternoon that industry veteran Lauren Silvernail will join its board of directors.

In addition to her board appointment, Silvernail will serve as chairperson of the clinical-stage immunotherapy company’s audit committee. Silvernail has more than three decades of experience, most recently serving as CFO and EVP of corporate development at Evolus. 

She also held leadership positions at Revance Therapeutics, Allergan and ISTA Pharmaceuticals.

“We look forward to Lauren’s guidance as we continue to execute our business plan and advance our novel class of T cell engagers in clinical trials,” Harpoon CEO Julie Eastland said in a statement.